upadacitinib atopic dermatitis
Selected indexed studies
- Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis. (Health Technol Assess, 2024) [PMID:38343072]
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. (JAMA Dermatol, 2021) [PMID:34347860]
- Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. (Lancet, 2021) [PMID:34023008]
_Worker-drafted node — pending editorial review._
Connections
upadacitinib atopic dermatitis is a side effect of
Sources
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. (2021) pubmed
- Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis. (2024) pubmed
- Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. (2023) pubmed
- JAK inhibitors in the treatment of atopic dermatitis. (2021) pubmed
- Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update. (2024) pubmed
- Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. (2023) pubmed
- Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. (2021) pubmed
- Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up). (2024) pubmed
- Upadacitinib for moderate to severe atopic dermatitis. (2023) pubmed
- Atopic Dermatitis in Children and Adults—Diagnosis and Treatment. (2023) pubmed